Iron-deficient anemia, anemia of chronic disease or mixed anemia: How to guide the diagnosis?;Anémie ferriprive, inflammatoire ou mixte: Comment orienter le diagnostic?

Revue Medicale Suisse

Volumn 7, Issue 313, 2011, Pages 2018-2023

  Celi, J ^a   Samii, K ^a   Perrier, A ^a   Reny, J L ^a  

^a Division d'Hématologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; CHRONIC DISEASE; DIAGNOSTIC PROCEDURE; IRON DEFICIENCY ANEMIA; IRON METABOLISM; MIXED ANEMIA; REVIEW; ALGORITHM; ARTICLE; HUMAN; METABOLISM;

IRON;

ALGORITHMS; ANEMIA, IRON-DEFICIENCY; HUMANS; IRON;

EID: 84855173317     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Lambert JF, Beris P. Pathophysiology and differential diagnosis of anaemia. In: Beaumont C, Béris P, Beuzard Y, Brugnara C. The Handbook on disorders of erythropoiesis, erythrocytes and iron metabolism. Paris: European school of haematology, 2009;108-41.
2. Beaumont C, Vaulont S. Iron homesostasis. In: Beaumont C, Béris P, Beuzard Y, Brugnara C. The Handbook on disorders of erythropoiesis, erythrocytes and iron metabolism. Paris: European school of haematology, 2009;489-509.
3. Wessling-Resnick M. Iron homeostasis and the inflammatory response. Ann Rev Nutr 2010;30:105-22.
4. Zhang AS, Enns C. Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Hematol Educ Program 2009;207-14.
5. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
6. * Ganz T. Hepcidin and iron regulation, ten years later. Blood 2011;117:4425-33.
7. Fleming M. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Am Soc Hematol Educ Program 2008;151-8.
8. Herklotz R, Huber A. Diagnostic de laboratoire des troubles du métabolisme du fer. Forum Med Suisse 2010;500-7.
9. Markovic M, Majkic-Singh N, Subota V. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest 2005;65;571-6. (Pubitemid 43160452)
10. Mast AE, Blinder MA, Gronowski AM, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998;44:45-51. (Pubitemid 28042465)
11. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-7. (Pubitemid 27121300)
12. Brugnara C. Reticulocyte cellular indices: A new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000;37:93-130. (Pubitemid 30258830)
13. * Mast AE, Blinder MA, Lu Q, et al. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002;99:1489-91.
14. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010;116:4754-61.
15. Nemeth E. Targeting the Hepcidin-Ferroportin axis in the diagnosis and treatment of anemias. Advances in Hematology, Volume 2010, Article ID 750643, 9 pages.
16. Thomas C, Kobold U, Thomas L. Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis. Clin Chem Lab Med 2011;49:207-13.
17. Waldvogel S, Canellini G, Lyon N, et al. Application of a commercially available competitive immunoassay to hepcidin quantification: What does it bring to clinical hematology? Forum Med Suisse 2010;10(Suppl. 50):94S. Annual meeting of the Swiss Society of Hematology; poster presentation.
18. * Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-76.
19. Brugnara C. Iron deficiency and erythropoiesis: New diagnostic approaches. Clin Chem 2003;49:1573-8. (Pubitemid 37194211)